Making Waves, Albeit Small Ones, in Orthopedics
Fulfilling its promise that it would use money raised in last year's IPO to begin an active acquisition campaign, DePuy Inc. announced this month that it would acquire 90% of the leading French implant company, Landanger-Camus [See Deal].
You may also be interested in...
The US FDA released five device-related close-out letters in March.
Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.
In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.